ERBB2 and breast carcinoma: Usually, breast cancers are divided into four subtypes, luminal A (LumA), luminal B (LumB), her2-enriched (Her2), and basal-like (Basal) by expression of the immunohistochemistry (IHC) markers (Table 1), and the order of patient outcomes according to molecular subtypes is well-known [15,25].